Beta Bionics Inc (BBNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 31,676 | 30,432 | 26,566 |
| Marketable Securities | 187,549 | 73,143 | 70,179 |
| Receivables | 17,118 | 11,996 | 4,448 |
| Inventories | 21,722 | 13,320 | 1,245 |
| TOTAL | $267,905 | $132,923 | $103,621 |
| Non-Current Assets | |||
| PPE Net | 8,600 | 4,776 | 2,476 |
| Investments And Advances | 45,431 | 0 | 0 |
| Other Non-Current Assets | 6,807 | 11,946 | 3,943 |
| TOTAL | $60,838 | $16,722 | $6,419 |
| Total Assets | $328,743 | $149,645 | $110,040 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 4,998 | 2,852 | 1,166 |
| Accrued Expenses | 22,431 | 15,828 | 8,128 |
| TOTAL | $30,924 | $21,148 | $10,605 |
| Non-Current Liabilities | |||
| Deferred Revenues | 1,557 | 939 | 87 |
| Other Non-Current Liabilities | 6,912 | 371,997 | 302,285 |
| TOTAL | $10,209 | $373,857 | $302,540 |
| Total Liabilities | $41,133 | $395,005 | $313,145 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 44,382 | N/A | N/A |
| Common Shares | 4 | 1 | 1 |
| Retained earnings | -369,937 | -296,737 | -229,664 |
| Other shareholders' equity | 403 | 65 | 137 |
| TOTAL | $287,610 | $-245,360 | $-203,105 |
| Total Liabilities And Equity | $328,743 | $149,645 | $110,040 |